33
person
Members of FasterCures Changemakers
Randy Beranek
CEO, National Psoriasis Foundation
Kathy Giusti
Executive Chairman, Multiple Myelom
a Research Foundation
Michael Kaplan
President and CEO, Melanoma Research Alliance
+ Read More
panel
FasterCures Advisory Groups Meeting (Invite only)
This session will bring together the FasterCures Advisory Board, Business Council, Nonprofit Cou
ncil, and Senior Fellows. Programmatic updates will be discussed and upcoming key events will be flagged for the engagement of all groups.
+ Read More
panel
FasterCures Advisors Meeting: A Conversation with Meena Seshamani (Invite only)
This annual meeting brings together the FasterCures Advisory Groups, including the Board, Busine
ss Council, and Changemakers nonprofit advisory council, to discuss timely topics across the biomedical research ecosystem. Dr.
+ Read More
panel
FasterCures Private Meeting (Invite only)
panel
FasterCures Board Meeting (Invite only)
landing page
Accelerating Innovation
At FasterCures, we aim to speed the delivery of treatments to all patients by addressing barriers to
the development of new products, by leveraging patients’ data responsibly and delivering direct benefits from contributing the
+ Read More
landing page
Antimicrobial Resistance
Antimicrobial resistance (AMR) has been called the silent pandemic.
landing page
Building Nonprofit Capacity
Since FasterCures’ inception in 2003, we have emphasized the importance of putting patients at the c
enter of the biomedical research system.
+ Read More
landing page
Strengthening Global Health
With the COVID-19 pandemic continuing to have a profound effect on lives and livelihoods here and ar
ound the world, one of the questions asked most frequently is, “How can we prevent this from happening again?” FasterCures init
+ Read More
landing page
Improving the Research and Development Environment
The COVID-19 pandemic revealed significant gaps in our health-care system, including in our clinical
trial infrastructure.
+ Read More
landing page
Lessons Learned from COVID-19
While the response to the COVID-19 pandemic exposed many of the fault lines in the biomedical innova
tion ecosystem that have slowed progress for decades, it also illustrated we are capable of innovating in ways we perhaps did n
+ Read More
landing page
Building Community-Based Infrastructure for Inclusive Research
COVID-19 revealed in stark terms the price to be paid for the lack of a comprehensive community-base
d research system that can generate evidence to answer a broad range of critical research questions, whether in the context of
+ Read More